News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Client Alert March 19, 2026
HSR Update: Fifth Circuit Order Enables Parties to Revert Immediately to Pre-2024 HSR Form
The FTC will continue to accept filings submitted under the 2024 Rule on a voluntary basis. The agency has not …
Client Alert February 13, 2026
Federal Court Vacates FTC’s 2024 HSR Premerger Notification Rule
Absent an appeal, the premerger notification requirements will revert to the prior HSR reporting rule on February 20, 2026.
Firm News November 14, 2025
Gibson Dunn Advising Merck on $9.2 Billion Acquisition of Cidara Therapeutics
Gibson Dunn is advising Merck on its $9.2 billion acquisition of Cidara Therapeutics, Inc., a biotechnology company developing drug-Fc conjugate (DFC) therapeutics
Firm News August 21, 2025
Gibson Dunn Lawyers Appointed to ABA Antitrust Section Leadership Roles
Thirteen Gibson Dunn lawyers have been appointed to leadership roles in the American Bar Association Antitrust Section.